FBXO32 and type 2 diabetes mellitus: ALF or treadmill exercise monotherapy for 2 weeks significantly decreased the expression of Atrogin-1 (p < 0.05) or MuRF1 (p < 0.05) compared with that of T2DM control rats (Cont group)(Fig 4B).